+48.8%
GSK vs SOXQ
+175.3%
-126.5%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SOXQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -10.7% | +10.5% | +0.2% |
| 7D | -5.3% | -17.1% | +11.7% | -4.9% |
| 30D | -3.7% | -26.8% | +23.2% | -3.0% |
| 3M | -7.3% | -28.6% | +21.4% | -6.6% |
| 6M | -4.2% | -28.7% | +24.4% | -4.0% |
| YTD | +0.9% | +19.1% | -18.2% | -2.6% |
| 1Y | +7.3% | +32.9% | -25.6% | +2.8% |
| 3Y | +52.7% | +125.0% | -72.2% | +38.6% |
| 5Y | +40.1% | +123.8% | -83.7% | +23.5% |
| All | +48.8% | +175.3% | -126.5% | +29.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SOXQ.
Daily Out/Under-Performance
Portfolio return minus SOXQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SOXQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SOXQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling